Antibody Engineering, Virus Retargeting and Cellular Immunotherapy: One Ring to Rule Them All?

E-ISSN： 1875-5631|5|1|63-70

ISSN： 1566-5232

Source： Current Gene Therapy, Vol.5, Iss.1, 2005-01, pp. : 63-70

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Development of Antibody-based Immunotherapy for Methamphetamine Abuse: Immunization, and Virus-Mediated Gene Transfer Approaches

Current Gene Therapy, Vol. 13, Iss. 1, 2013-02 ,pp. : 39-50

Bentham Science Publishers

Access to resources Recommend Favorite

Antibody-mediated specific immunotherapy of allergy

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 6, 2002-06 ,pp. : 949-952

Informa Healthcare

Access to resources Recommend Favorite

Monoclonal Antibody-based Genetic Immunotherapy

Current Gene Therapy, Vol. 4, Iss. 3, 2004-09 ,pp. : 347-356

Bentham Science Publishers

Access to resources Recommend Favorite

Genetic Engineering of Allergens for Immunotherapy

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 8, Iss. 2, 2009-06 ,pp. : 104-109

Bentham Science Publishers

Access to resources Recommend Favorite

Antibody Library Display on a Mammalian Virus Vector: Combining the Advantages of Both Phage and Yeast Display into One Technology

Current Drug Discovery Technologies, Vol. 11, Iss. 1, 2014-03 ,pp. : 48-55

Bentham Science Publishers

Access to resources Recommend Favorite